Reports Documents Safety Violations By Compounding Pharmacies
By Alexandra Hill, WBGO News
May 23, 2013
A new report released today says pharmacies that are meant to customize individual prescriptions are racking up safety violations and manufacturing dangerous drugs that could end up on the shelves of your local pharmacies.
The report, by consumer advocacy group NJPIRG, finds that from 2002 to 2012 the FDA issued more than 40 warning letters to compounding pharmacies, including 5 in New Jersey. They were cited for violations such as making new drugs that were never tested for safety and making drugs in unsanitary conditions. NJPIRG Spokesperson Jen Coleman says they are exploiting legal loopholes.
“Because compounded drugs are not FDA approved and they’re not really able to be regulated by the state board of pharmacy, compounding pharmacies are generally not registering with the FDA and they’re not telling the FDA what drugs they’re making.”
Coleman says the only real solution is for the FDA to regulate these companies in the same way as the large pharmaceutical companies.